1 / 3
google
Article details
- Package size
- 25
- Selling units
- 25
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
150.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 119.05
Specialties list
Yes
Generic
No
SL addition date:
15/03/1978
Authorization holder
Aspen Pharma Schweiz GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 37890
- Drug name
- Lanvis, Tabletten
- Galenic form
- TAB
- ATC Code
- L01BB03
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 01/06/1973
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- LANVIS cpr 40 mg fl 25 pce
- Description (DE)
- LANVIS Tabl 40 mg Fl 25 Stk
- Market launch
- 01/06/1973
- Narcotic (BTM)
- No